SAN DIEGO—Matthew Singleton, a director at Viking Therapeutics, Inc. (NASDAQ:VKTX), recently executed a significant stock sale, according to a filing with the Securities and... ByInvesting.com ...

Justin Zelin, an analyst from BTIG, reiterated the Buy rating on Mersana Therapeutics (MRSN – Research Report). The associated price ...

While Novo Nordisk and Lilly are the undisputed leaders in weight management right now, a number of pharmaceutical companies ...

The Northeast Tennessee Health Department reminded families to keep food safe and prevent foodborne illness when cooking for ...

Amazon One Medical is expanding its telehealth services with the launch of upfront and low-cost treatment plans and ...

One dedicated fan and hardworking nurse is getting a special treat, thanks to a partnership between Dunkin' and UGA Athletics ...

"Vergent concludes enrolment for lung cancer study of VGT-309" was originally created and published by Clinical Trials Arena, ...